Promoters of drugmaker Cipla are expected to offload 2.53% of their stake in a block deal worth Rs 2637 crore on Wednesday, according to so...

The price range of the block is fixed at Rs 1,289-1,357, taking the total deal value to around Rs 2,637 crore.

Samina Hamied, executive vice-chairperson of Cipla, announced her decision to step down from her executive role due to personal and family ...

Torrent Pharma's attempt to acquire the stake of the Hamied family in Cipla has hit a roadblock due to differences in valuation. Talks betw...

Cipla's potential stake sale faces a challenge due to disagreements among its promoters regarding the company's valuation. This dispute amo...

Prospective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding f...

Ahmedabad-based Torrent Pharma is seeking financing for a deal with Indian pharmaceutical company Cipla. Torrent Pharma is interested in bu...

Torrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...

Rival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among othe...

Blackstone may submit a non-binding bid next week for the Hamied family's stake in the company. This will formally start a process which co...

The transfer of shares is being done by way of gift, the filing said, adding that the purpose was "Re-alignment of family shareholding".

Cipla patriarch YK Hamied plans to increase his holding to over 20 per cent by acquiring over 5 per cent additional stake in the homegrown ...

All promoters put together hold 36.8 per cent stake in Cipla, while Yusuf Hamied individually owns 15.55 per cent. His sister Sophie holds ...

Cipla's promoter family has proposed to vote together as a single unit under overall direction of patriarch Yusuf Hamied in his lifetime, a...

While Cipla paid Rs 29 crore for Okasa’s facility in Goa, it bought another plant, owned by Okasa Pharma, located in Satara for Rs 71.93 cr...

The acquisition is part of a two-way transaction under which the Yusuf Khwaja Hamied-run Cipla's wholly-owned arm Medispray Laboratories co...

Pharma major Cipla on Thursday said it is expecting to scale up its revenue by over six times to Rs 15,000-20,000 crore.